MPM Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

MPM Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-909,258	Closed	-$3.77M	–	10
2022 Q2	$3.77M	Hold	909,258	–	–	1.59%	9
2022 Q1	$10.5M	Hold	909,258	–	–	3.58%	9
2021 Q4	$9.07M	Hold	909,258	–	–	1.96%	10
2021 Q3	$11.9M	Hold	909,258	–	–	2.75%	9
2021 Q2	$17.8M	Hold	909,258	–	–	3.31%	9
2021 Q1	$19.3M	Sell	909,258 -1,000,000	-52%	-$29M	3.74%	7
2020 Q4	$56.8M	Hold	1,909,258	–	–	8.03%	7
2020 Q3	$41.4M	Hold	1,909,258	–	–	7.72%	6
2020 Q2	$42.6M	Sell	1,909,258 -450,205	-19%	-$8.77M	12.67%	4
2020 Q1	$35.9M	Sell	2,359,463 -34,034	-1%	-$609K	21.85%	2
2019 Q4	$55M	Sell	2,393,497 -681,396	-22%	-$15.1M	24.19%	3
2019 Q3	$66.4M	Hold	3,074,893	–	–	28.41%	1
2019 Q2	$67.6M	Hold	3,074,893	–	–	27.34%	1
2019 Q1	$84.3M	Hold	3,074,893	–	–	34.75%	1
2018 Q4	$82.7M	Hold	3,074,893	–	–	69.94%	1
2018 Q3	$89.7M	Hold	3,074,893	–	–	60.73%	1
2018 Q2	$96.1M	Buy	3,074,893 +378,501	+14%	+$10.3M	37.23%	2
2018 Q1	$53.7M	Hold	2,696,392	–	–	20.67%	2
2017 Q4	$78.4M	Buy	+2,696,392	New	+$71.3M	31.4%	2

Other funds holding RYTM

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

MPM Asset Management's RYTM Position: Q3 2022 in Review

MPM Asset Management sold out of Rhythm Pharmaceuticals (RYTM) in Q3 2022, closing a stake of 909,258 shares — an estimated $3.77M sold.

MPM Asset Management first reported a position in RYTM in Q4 2017 and held it in 19 quarters. The position peaked at $96.1M in Q2 2018. 101 funds tracked by Wall St. Rank hold RYTM as of Q3 2022.

MPM Asset Management reported no remaining Rhythm Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
MPM Asset Management sold 909,258 Rhythm Pharmaceuticals shares in Q3 2022, an estimated $3.77M.
MPM Asset Management first reported a position in Rhythm Pharmaceuticals in Q4 2017 and held it in 19 quarters.
MPM Asset Management's Rhythm Pharmaceuticals position peaked at $96.1M in Q2 2018.
101 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2022.

Based on MPM Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.